Galena Biopharma, Inc.
(NASDAQ : GALE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading GALE News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.06%69.331.0%$931.92m
AMGNAmgen Inc.
0.29%173.630.8%$658.36m
BIIBBiogen Inc.
0.10%287.180.9%$537.13m
CELGCelgene Corporation
0.07%119.521.0%$480.31m
REGNRegeneron Pharmaceuticals, Inc.
-0.37%370.231.9%$347.09m
ALXNAlexion Pharmaceuticals, Inc.
1.21%131.462.0%$303.19m
TSROTESARO, Inc.
0.28%190.8015.3%$199.54m
INCYIncyte Corporation
-0.04%122.312.3%$170.05m
ILMNIllumina, Inc.
0.53%163.013.9%$148.80m
VRTXVertex Pharmaceuticals Incorporated
0.15%86.682.6%$140.28m
CLVSClovis Oncology, Inc.
0.54%63.3316.4%$133.08m
EXELExelixis, Inc.
-1.81%22.695.5%$129.08m
AAgilent Technologies, Inc.
0.37%51.541.7%$117.70m
ACADACADIA Pharmaceuticals Inc.
0.00%39.2019.0%$93.83m
BMRNBioMarin Pharmaceutical Inc.
-0.02%90.224.0%$89.96m

Company Profile

Galena Biopharma, Inc. is a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA.